Liquid Microbial Control Filters - Selection Guide

Large-volume parenterals (typically greater than 100 ml) of intravenous or ophthalmic solutions packed in bags or bottles with little or no requirement for upstream and downstream processing

Low-dose volume, small-molecule drugs that originate from chemical synthesis, natural products and extracts or industrial bacteria and fungal fermentations

Albumin and therapeutics derived from human blood plasma, such as immunoglobulins and blood factors

Live-attenuated vaccines, inactivated vaccines, subunit, recombinant, polysaccharide and conjugate vaccines using traditional and modern methods

Biological drugs that originate from mammalian or microbial cells, including monoclonal antibodies and recombinant proteins

Recombinant viral vectors made by either mammalian or insect cells and used for in vivo gene modification, ex vivo gene modification, vaccines or as oncolytic viruses

Non-viral based nucleic acids such as plasmid DNA or mRNA produced using either microbial or synthetic processes and used for in vivo or ex vivo gene modification, vaccines or to produce viral vectors